Amicogen, Inc.
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
092040 | KO
Overview
Corporate Details
- ISIN(s):
- KR7092040005
- LEI:
- Country:
- South Korea
- Address:
- 경상남도 진주시 문산읍 월아산로950번길 14-10 아미코젠 문산 1공장, 진주시
- Website:
- http://amicogen.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Amicogen, Inc. is an industrial biotechnology company founded in 2000 that specializes in the research, development, and production of special enzymes and other bio-new materials. Leveraging its core enzyme technology, the company provides solutions for the pharmaceutical and healthcare sectors. Its business areas include developing functional ingredients for health and nutrition through its KNUTRA brand, producing cell culture media, and offering Contract Development and Manufacturing Organization (CDMO) services for the bioprocess industry. Amicogen is focused on creating sustainable value for human health and the environment through continuous innovation and R&D.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-09-18 00:00 |
Share Issue/Capital Change
전환가액의조정 (제4회차)
|
Korean | 10.6 KB | ||
| 2025-09-17 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-20 00:00 |
Regulatory News Service
불성실공시법인지정 (공시변경)
|
Korean | 6.0 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 2.3 MB | ||
| 2025-08-11 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시) (제6회차 CB)
|
Korean | 5.6 KB | ||
| 2025-08-01 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 49.8 KB | ||
| 2025-07-30 00:00 |
Legal Proceedings Report
소송등의판결ㆍ결정(일정금액이상의청구) (대여금 청구-취하)
|
Korean | 7.0 KB | ||
| 2025-07-28 00:00 |
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 7.3 KB | ||
| 2025-07-25 00:00 |
Regulatory News Service
불성실공시법인지정예고
|
Korean | 4.9 KB | ||
| 2025-07-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-06-25 00:00 |
Regulatory News Service
[기재정정]신규시설투자등
|
Korean | 12.1 KB | ||
| 2025-05-23 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.9 MB |
Automate Your Workflow. Get a real-time feed of all Amicogen, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amicogen, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amicogen, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
